title: Light chain (AL) amyloidosis: update on diagnosis and management.
abstract: Light chain (AL) amyloidosis is a plasma cell dyscrasia characterized by the pathologic production of fibrillar proteins comprised of monoclonal light chains which deposit in tissues and cause organ dysfunction. The diagnosis can be challenging, requiring a biopsy and often specialized testing to confirm the subtype of systemic disease. The goal of treatment is eradication of the monoclonal plasma cell population and suppression of the pathologic light chains which can result in organ improvement and extend patient survival. Standard treatment approaches include high dose melphalan (HDM) followed by autologous hematopoietic stem cell transplantation (SCT) or oral melphalan with dexamethasone (MDex). The use of novel agents (thalidomide, lenalidomide and bortezomib) alone and in combination with steroids and alkylating agents has shown efficacy and continues to be explored. A risk adapted approach to SCT followed by novel agents as consolidation reduces treatment related mortality with promising outcomes. Immunotherapeutic approaches targeting pathologic plasma cells and amyloid precursor proteins or fibrils are being developed. Referral of patients to specialized centers focusing on AL amyloidosis and conducting clinical trials is essential to improving patient outcomes.
authors.affiliation: City of Hope National Cancer Center, Duarte, California, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Rosenzweig
authors.forename: Heather
authors.initials: H
authors.lastname: Landau
mesh_terms: D000686:Amyloidosis / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy*; D000818:Animals; D003907:Dexamethasone / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000378:metabolism; D000075363:Immunoglobulin Light-chain Amyloidosis; D008558:Melphalan / Q000627:therapeutic use; D010265:Paraproteinemias / Q000175:diagnosis / Q000628:therapy
chemical_list: D007147:Immunoglobulin Light Chains; D003907:Dexamethasone; D008558:Melphalan
references.citation: Leuk Lymphoma. 2008 Jan;49(1):36-41
references.pmid: 18203009
references.citation: Br J Haematol. 2008 Nov;143(3):369-73
references.pmid: 18691169
references.citation: Ann Intern Med. 2004 Jan 20;140(2):85-93
references.pmid: 14734330
references.citation: Blood. 2007 Jul 15;110(2):787-8
references.pmid: 17606766
references.citation: Clin Lymphoma. 2003 Mar;3(4):241-6
references.pmid: 12672274
references.citation: Leukemia. 2009 Feb;23(2):215-24
references.pmid: 19020545
references.citation: Br J Haematol. 2007 Oct;139(2):224-33
references.pmid: 17897298
references.citation: Blood. 1996 Oct 1;88(7):2801-6
references.pmid: 8839879
references.citation: Amyloid. 2003 Dec;10(4):257-61
references.pmid: 14986485
references.citation: Amyloid. 2002 Jun;9(2):108-14
references.pmid: 12440483
references.citation: Nature. 2010 Nov 4;468(7320):93-7
references.pmid: 20962779
references.citation: Blood. 2004 Apr 15;103(8):2936-8
references.pmid: 15070667
references.citation: N Engl J Med. 2007 Sep 13;357(11):1083-93
references.pmid: 17855669
references.citation: Cancer Biother Radiopharm. 2003 Dec;18(6):853-60
references.pmid: 14969598
references.citation: Blood. 2009 Dec 3;114(24):4957-9
references.pmid: 19797517
references.citation: Am J Hematol. 2006 Apr;81(4):281-3
references.pmid: 16550508
references.citation: Bone Marrow Transplant. 1997 Nov;20(10):907-8
references.pmid: 9404936
references.citation: Blood. 2005 Jul 1;106(1):167-74
references.pmid: 15761016
references.citation: Blood. 2009 Jul 9;114(2):310-7
references.pmid: 19436053
references.citation: Am J Hematol. 2005 Aug;79(4):319-28
references.pmid: 16044444
references.citation: Semin Hematol. 1995 Jan;32(1):45-59
references.pmid: 7878478
references.citation: Nat Rev Rheumatol. 2010 Jul;6(7):417-29
references.pmid: 20531382
references.citation: Blood. 2007 Jan 15;109(2):492-6
references.pmid: 16960148
references.citation: Br J Haematol. 1998 Jan;100(1):226-8
references.pmid: 9450816
references.citation: Arch Intern Med. 1961 Mar;107:344-53
references.pmid: 13755566
references.citation: Am J Hematol. 2011 Feb;86(2):180-6
references.pmid: 21264900
references.citation: Clin Rev Allergy Immunol. 2010 Apr;38(2-3):97-106
references.pmid: 19626465
references.citation: Blood. 1998 May 15;91(10):3662-70
references.pmid: 9573002
references.citation: Blood. 2010 Dec 2;116(23):4777-82
references.pmid: 20724537
references.citation: Blood. 2007 Nov 15;110(10):3561-3
references.pmid: 17673601
references.citation: N Engl J Med. 1997 Sep 25;337(13):898-909
references.pmid: 9302305
references.citation: Leukemia. 2008 Feb;22(2):414-23
references.pmid: 18094721
references.citation: Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5602-6
references.pmid: 8202534
references.citation: Leuk Lymphoma. 2010 Dec;51(12):2181-7
references.pmid: 20958232
references.citation: Br J Haematol. 2001 Jun;113(4):1044-6
references.pmid: 11442500
references.citation: Haematologica. 2007 Oct;92(10):1351-8
references.pmid: 18024372
references.citation: Blood. 2006 Mar 15;107(6):2578-84
references.pmid: 16293611
references.citation: Curr Hematol Malig Rep. 2009 Apr;4(2):91-8
references.pmid: 20425420
references.citation: Ann Hematol. 2011 Jan;90(1):101-6
references.pmid: 20645101
references.citation: Eur J Haematol. 2004 Jun;72(6):448-50
references.pmid: 15128426
references.citation: Blood. 2009 Aug 20;114(8):1489-97
references.pmid: 19498019
references.citation: Annu Rev Med. 2006;57:223-41
references.pmid: 16409147
references.citation: N Engl J Med. 1997 Apr 24;336(17):1202-7
references.pmid: 9110907
references.citation: Blood. 2006 May 1;107(9):3489-91
references.pmid: 16439680
references.citation: Br J Haematol. 2010 Mar;148(5):760-7
references.pmid: 20064157
references.citation: Med Electron Microsc. 2001 Mar;34(1):1-18
references.pmid: 11479769
references.citation: Am J Clin Pathol. 2004 Jun;121(6):787-9
references.pmid: 15198347
references.citation: N Engl J Med. 2002 Jun 6;346(23):1786-91
references.pmid: 12050338
references.citation: Curr Opin Oncol. 2007 Mar;19(2):136-41
references.pmid: 17272986
references.citation: Bone Marrow Transplant. 2004 Dec;34(12):1025-31
references.pmid: 15516945
references.citation: Br J Haematol. 2002 Jun;117(4):886-9
references.pmid: 12060126
references.citation: Am J Pathol. 2000 Oct;157(4):1239-46
references.pmid: 11021828
references.citation: Nature. 2002 May 16;417(6886):254-9
references.pmid: 12015594
references.citation: N Engl J Med. 2008 Jan 3;358(1):91; author reply 92-3
references.pmid: 18172183
references.citation: Haematologica. 2007 Oct;92(10):1415-8
references.pmid: 17768110